Mitchell Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Mitchell Capital Management's BIIB Position: Q1 2019 in Review
Mitchell Capital Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 14,183 shares — an estimated $4.27M sold.
Mitchell Capital Management first reported a position in BIIB in Q2 2013 and held it in 23 quarters. The position peaked at $13.1M in Q4 2014. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.
- Mitchell Capital Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
- Mitchell Capital Management sold 14,183 Biogen shares in Q1 2019, an estimated $4.27M.
- Mitchell Capital Management first reported a position in Biogen in Q2 2013 and held it in 23 quarters.
- Mitchell Capital Management's Biogen position peaked at $13.1M in Q4 2014.
- 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.
Based on Mitchell Capital Management's 13F filing for Q1 2019, filed 2 May 2019.